HAE: HAEMONETICS CORP insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 0 sales totaling - in the last 180 days.

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-12Fell below 5%AQR Capital Management, LLC4.99%SEC

Institutional ownership (Q2 2026)

330 institutions reported holding $3.57B of HAEMONETICS CORP on Form 13F (324 the quarter before). 52 opened a new position and 46 sold out. Shares held by institutions: +4%.

Largest holdersSharesValue
BlackRock, Inc.5,909,258$443.19M
NEUBERGER BERMAN GROUP LLC4,179,443$313.47M
VANGUARD PORTFOLIO MANAGEMENT LLC2,546,394$190.98M
AQR CAPITAL MANAGEMENT LLC2,266,489$165.02M
ARIEL INVESTMENTS, LLC2,060,966$154.57M
VANGUARD CAPITAL MANAGEMENT LLC2,059,578$154.47M
STATE STREET CORP1,818,186$136.36M
DIMENSIONAL FUND ADVISORS LP1,585,222$118.89M
CITADEL ADVISORS LLC1,510,120$113.26M
GEODE CAPITAL MANAGEMENT, LLC1,287,240$96.56M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.